Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination

BACKGROUND: To assess the immune persistence conferred by a Chinese hamster ovary (CHO)-derived hepatitis B vaccine (HepB) 17 to 20 years after primary immunization during early life. METHODS: Participants born between 1997 and 1999 who received a full course of primary vaccination with HepB (CHO) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yu-Liang, Han, Bi-Hua, Zhang, Xin-Jiang, Pan, Lu-Lu, Zhou, Hai-Song, Gao, Zhao, Hao, Zhi-Yong, Wu, Zhi-Wei, Ma, Tian-Li, Wang, Feng, Li, Qi, Bi, Sheng-Li, Ma, Jing-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543564/
https://www.ncbi.nlm.nih.gov/pubmed/31146699
http://dx.doi.org/10.1186/s12879-019-4134-9

Ejemplares similares

Ejemplares similares